The 20 Best Urothelial Cancer Doctors Near Me in Alexandria, VA

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Smith is board certified in American Board Of Urology.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Michael Kaplan is a Radiologist practicing medicine in Alexandria, Virginia. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Ascites, Breast Cancer, Pleurisy, Bone Marrow Aspiration, and Liver Embolization.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

Andrew Akman, MD, MBA a native of Washington, DC, currently practices at Suburban Hospital, Sibley Hospital, and Johns Hopkins Hospital. Dr. Akman performs a variety of minimally invasive procedures. He has specific interest in complex IVC filter removals, interventional oncology, pulmonary embolism, and prostate artery embolization. Dr. Akman is an expert in complex IVC filter retrieval and IVC filter related complications. In addition to standard IVC filter retrievals, he removes devices that are severely tilted, embedded, or fractured, as well as those designated as permanent devices. He serves as an adviser to other physicians on complex techniques including laser sheath and forceps assisted retrieval. Within interventional oncology, Dr. Akman performs thermal ablation of lung, liver, and kidney tumors. He performs chemoembolization and radioembolization (Yttrium-90) on primary liver cancer and metastatic liver disease. Dr. Akman also performs prostate artery embolization, an emerging minimally invasive technique for treating urinary symptoms associated with prostate enlargement. Dr. Akman prides himself on building strong relationships with his patients and practicing patient-centered medicine. Videos Andrew Akman, M.D., Interventional Radiologist Recent News Articles and Media Coverage Honoring a Life By Helping Others, Johns Hopkins Medicine, (July 20, 2022). Dr. Akman is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Ascites, Ureterocele, Familial Pancreatic Cancer, Gastrostomy, and Liver Embolization. Dr. Akman is board certified in American Board Of Radiology.

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Ureterocele, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Jarrett is board certified in American Board Of Urology.

Gregory Bernstein is a Urologist practicing medicine in Alexandria, Virginia. Dr. Bernstein is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Nephrectomy.

James Cooper is a Radiologist and an Interventional Radiologist practicing medicine in Alexandria, Virginia. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Ascites, Lung Cancer, End-Stage Renal Disease (ESRD), Bone Marrow Aspiration, and Gastrostomy.

Jacob Ninan is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Ninan is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Pulmonary Embolism, Saddle Pulmonary Embolism, and Colorectal Cancer.

Ivan Aksentijevich is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Aksentijevich is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma.

Alina Huang is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Huang is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Pulmonary Embolism.

Jeffrey Wong is a Urologist practicing medicine in Alexandria, Virginia. Dr. Wong is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy.

Dr. Ramez I. Andrawis is a urologist affiliated with Sibley Memorial Hospital and George Washington University Hospital, where he is an assistant professor of urology and the director of the Urology Lab. He practices out of GW Medical Faculty Associates in Washington, D.C. Dr. Andrawis has an expertise in female urology, benign prostatic hyperplasia, urinary incontinence and reconstructive surgery. Dr. Andrawis earned his undergraduate and medical degree from the University of Cairo in Egypt, where he went on to complete a residency in urology. Dr. Andrawis also completed a residency in urology at the Royal College of Surgeons in Ireland, a general surgery residency at New Britain General Hospital and a urology residency at George Washington University Hospital. Dr. Andrawis has been named a Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly. Dr. Andrawis has contributed to numerous publications on urology. Dr. Andrawis is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Bilateral Hydronephrosis, and Ureteroscopy. Dr. Andrawis is board certified in American Board Of Urology.

Andrew Joel is a Urologist practicing medicine in Arlington, Virginia. Dr. Joel is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Robert Mordkin is a Urologist practicing medicine in Arlington, Virginia. Dr. Mordkin is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Ross Krasnow is a Urologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 17 years. Dr. Krasnow is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Nephrectomy, and Cystectomy.

Justin O. Benabdallah, M.D., is a urologist at Sibley Memorial Hospital, as well as an assistant professor of urology with the Brady Urological Institute and Department of Urology at Johns Hopkins Medicine. Dr. Benabdallah’s uses minimally invasive and robotic surgery techniques in the treatment of prostate and kidney cancer and has expertise in endourology for the treatment of kidney stones. He also specializes in men’s health, including erectile dysfunction, male infertility, vasectomy and enlarged prostate. Dr. Benabdallah earned his medical degree from Virginia Commonwealth University School of Medicine. He completed an internship and residency in urology at the Medical College of Wisconsin. Dr. Benabdallah also completed a fellowship in endourology and minimally invasive urology at Washington University School of Medicine in St. Louis, Missouri, where he served as a clinical instructor in urology. Dr. Benabdallah is a member of the American Urologic Society and the Endourology Society. Dr. Benabdallah earned the Dr. Anna Smither Award for Neurourology Research and the Housestaff Research Award from the Medical College of Wisconsin. Dr. Benabdallah has contributed to numerous publications and presentations on topics of urology. LinkedIn https://www.linkedin.com/in/justin-benabdallah-b827b3131 Videos Justin Benabdallah, M.D. Recent News Articles and Media Coverage Physicians taking the lead during 'Movember'. Fox 6 News. 11/30/2012. Dr. Benabdallah is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Nephrectomy. Dr. Benabdallah is board certified in American Board Of Urology.

Dr. Patrick Mufarrij is a member of the Johns Hopkins Brady Urologic Institute at Sibley Memorial Hospital and is an expert in endourology, including percutaneous and endoscopic urologic surgery; metabolic stone and causes of the recurrent stone formation; and robotic surgery for the reconstruction of the urinary tract. He also serves as the Division Cheif for Urology at Sibley Memorial Hospital. Dr. Mufarrij earned his undergraduate degree and his medical degree from Georgetown University School of Medicine. He completed residencies in general surgery and urology at New York University School of Medicine, followed by special training in endourology during a fellowship at Wake Forest Baptist Medical Center. During his fellowship, Dr. Mufarrij focused on metabolic kidney stone disease, surgery for complex kidney stones, percutaneous renal surgery and robotic surgery. Dr. Mufarrij is a member of the American Urological Association. Dr. Mufarrij has contributed to numerous publications on the topics of urology. Dr. Mufarrij is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Perirenal Abscess, Carbuncle, Ureteroscopy, and Lithotripsy. Dr. Mufarrij is board certified in American Board Of Urology.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

Arjun Sood is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Sood is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.